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During the revision of our manuscript, two research groups independently reported that reduced IGF signaling is protective toward
Alzheimer’s disease-related pathology. We would like to direct readers to the following references:
Freude, S., Hettich, M.M., Schumann, C., Sto¨hr, O., Koch, L., Ko¨hler, C., Udelhoven, M., Leeser, U., Mu¨ller, M., Kubota, N., et al.
(2009). Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer’s
disease. FASEB J. 23, 3315–3324.
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(2009). Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem. Biophys. Res.
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